UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000045958 |
|---|---|
| Receipt number | R000052456 |
| Scientific Title | Effect of air purification and humidification on asthma. |
| Date of disclosure of the study information | 2021/11/02 |
| Last modified on | 2021/11/24 14:36:35 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effect of air purification and humidification on asthma.
Acronym
Effect of air purification and humidification on asthma.
Scientific Title
Effect of air purification and humidification on asthma.
Scientific Title:Acronym
Effect of air purification and humidification on asthma.
Region
| Japan |
Condition
Condition
asthma
Classification by specialty
| Pneumology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
We are conducting a questionnaire survey onasthma symptoms before and after using a humidifi ed air purifi er. by comparing the results,we will examine how streamer air purifi cationtechnology and humidifi cation technology aff ect the asthma symptoms.
In addition, we will also acquire air quality data in the living environment of the subjects andexamine the relationship between the occurrence of asthma and asthma symptoms and airquality.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Association of asthmatic symptoms with use of the air purifi cation alone and with humidifi cation function.
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Cross-over
Randomization
Randomized
Randomization unit
Individual
Blinding
Open -no one is blinded
Control
No treatment
Stratification
YES
Dynamic allocation
NO
Institution consideration
Institution is not considered as adjustment factor.
Blocking
YES
Concealment
No need to know
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Other |
Interventions/Control_1
use of air purifi cation
Interventions/Control_2
use of air purifi cation and humidifi cation
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 12 | years-old | <= |
Age-upper limit
| 120 | years-old | > |
Gender
Male and Female
Key inclusion criteria
1)Males and females aged 12 years or older attime of informed consent.
2)Informed written consent from patients or authorized guardians.
3)Patients who have not used an air purifi er orhumidifi er in the last 3 months.
4)Patients who have been diagnosed with asthma and have visited a medical institution within one year.
Key exclusion criteria
1)Patients who have a history of other respiratory disease(lung cancer, interstitial pneumonia, etc.).
2)Smokers, households with smokers.
3)Patients who have serious or unstable liver,kidney, digestive, respiratory, cardiovascular (including ischemic heart disease), endocrine, neuro logical, psychological, immune or blood disorders that may aff ect the study.
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | Tomohiro |
| Middle name | |
| Last name | Yabu |
Organization
DAIKIN (CHINA) INVESTMENT CO., LTD.
OPEN INNOVATION LAB. SHENZHEN
Division name
R&D DEPT.
Zip code
518052
Address
5/F BLOCK 1, VISEEN BUSINESS PARK, 43 GAOXIN SOUTH RING ROAD, NANSHAN DISTRICT, SHENZHEN, CHINA
TEL
+86-188-2691-1831
tomohiro.yabu@daikin.co.jp
Public contact
Name of contact person
| 1st name | Tomohiro |
| Middle name | |
| Last name | Yabu |
Organization
DAIKIN (CHINA) INVESTMENT CO., LTD. OPEN INNOVATION LAB. SHENZHEN
Division name
R&D DEPT.
Zip code
518052
Address
5/F BLOCK 1, VISEEN BUSINESS PARK, 43 GAOXIN SOUTH RING ROAD, NANSHAN DISTRICT, SHENZHEN, CHINA
TEL
+86-188-2691-1831
Homepage URL
tomohiro.yabu@daikin.co.jp
Sponsor or person
Institute
DAIKIN (CHINA) INVESTMENT CO., LTD. OPEN INNOVATION LAB. SHENZHEN
Institute
Department
Personal name
Funding Source
Organization
DAIKIN (CHINA) INVESTMENT CO., LTD. OPEN INNOVATION LAB. SHENZHEN
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Japan Conference of Clinical Research
Address
1-13-23, Minamiikebukuro, Toshima-ku, Tokyo
Tel
03-6868-7022
jccr-info@jccr.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 11 | Month | 02 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2021 | Year | 10 | Month | 21 | Day |
Date of IRB
| 2021 | Year | 10 | Month | 21 | Day |
Anticipated trial start date
| 2021 | Year | 11 | Month | 01 | Day |
Last follow-up date
| 2022 | Year | 02 | Month | 28 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
| 2022 | Year | 12 | Month | 31 | Day |
Other
Other related information
Management information
Registered date
| 2021 | Year | 11 | Month | 02 | Day |
Last modified on
| 2021 | Year | 11 | Month | 24 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052456
